Publikationen suchen
- Publikation
- Autoren
- Einrichtungen
- Abstract
- Externe Dokumente
- Links
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML)
(
Zeitschriftenartikel
)
